Senate Panel Wants To Keep Blocking DC From Legal Marijuana Sales, While Pushing Feds To Continue Cannabis Drug Testing Under Rescheduling
Key Takeaway
A key U.S. Senate committee has released spending bills and attached reports that would keep blocking local officials in Washington, D.C. from legalizing recreational marijuana sales and direct federal officials to continue drug testing safety sensitive workers for cannabis even under rescheduling-while also recognizing the therapeutic potential of psychedelics and noting that Schedule I status
What This Means for Cannabis Businesses
Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.
Find Help
Related News
Virginia Legislature Sends Cannabis Sales Legalization Bill to Governor
Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back
IRS Disputes Cannabis Company's Challenge to 280E in Tax Court
Michigan Cannabis Sales Fall to Lowest Level in Two Years Under New Wholesale Tax
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.